Surgical treatment is one of the most effective means of treating osteosarcoma. By improving pre-operative investigations, staging the patient’s condition and individualising the choice of surgery, the long-term survival rate…
There is no evidence to support the hereditary nature of osteosarcoma.
In addition to the primary tumor, bone is also a common site of metastasis for other malignant tumors, such as breast cancer, prostate cancer, thyroid cancer, bladder cancer, lung cancer,…
Osteosarcoma is a malignant tumor with a very low incidence. The most important progress in the treatment of osteosarcoma in the past 30 years has been the use of neoadjuvant…
Reconstruction of large bone defects after bone tumor resection has always been a challenge. There are many reconstruction methods, such as tumor prosthesis, allograft, distraction osteogenesis, and autologous bone graft,…
Osteosarcoma is the most common malignant bone tumor in childhood and adolescence, and the application of neoadjuvant chemotherapy as well as high-dose chemotherapy has effectively improved the 5-year survival rate…
In the past 30 years due to the use of neoadjuvant chemotherapy and adjuvant chemotherapy, the survival rate of patients with osteosarcoma has dramatically improved. In bone tumor centers, surgery…
Osteosarcoma 80% already have potential lung metastases at the time of initial presentation Prior to the advent of adjuvant chemotherapy, the 5-year survival rate was only 10-20%, and 90% of patients died…
Osteosarcoma is a primary malignant bone or soft tissue tumor arising from osteogenic mesenchymal cells. There are many subtypes of osteosarcoma: typical osteosarcoma, low-grade malignant intramedullary osteosarcoma, osteosarcoma secondary to…
Osteosarcoma, also known as osteogenic sarcoma, is a malignant bone tumor that occurs mostly in adolescents or children under the age of 20. Osteosarcoma develops from a…